Recently, the official website of the Hainan Provincial Health Commission showed that the innovative digital therapy solutions for diabetes declared by Suzhou Yiduoyun Information Technology Co., Ltd. were successfully selected into the "2+3" health Service pack diabetes digital therapy innovative application scenarios and solutions collection. It is understood that the Hainan Provincial Government attaches great importance to the implementation of the "2+3" health Service pack, which includes hypertension, diabetes, tuberculosis, hepatitis, and severe mental disorders. Among them, diabetes, as one of the chronic diseases affecting the health of Chinese residents, may lead to serious consequences such as cardio cerebral Vascular disease, blindness, foot gangrene, chronic renal failure, etc. if not treated properly. However, there are still a series of problems in the prevention and treatment of diabetes, including poor treatment compliance, lack of lifestyle intervention measures, insufficient management services for patients outside the hospital, and weak health management and service capabilities at the grass-roots level. In order to effectively address these challenges, digital therapy, as a new Digital health solution, has prominent advantages in coordinating medical and non-medical factors of disease prevention and treatment, coordinating the scenes inside and outside the hospital, rapidly empowering grassroots and supporting digital precision governance. According to the comprehensive evaluation of the professional jury, the innovative solution of diabetes digital therapy provided by Suzhou Yiduoyun Information Technology Co., Ltd. has been successfully selected into this solicitation activity and will carry out pilot work in advance this year. It is reported that Yiduoyun's "innovative solution for diabetes intelligent digital therapy" was jointly proposed by Yiduoyun, Tsinghua Changgeng Hospital and Tsinghua Intelligent Medical Research Institute according to the current national diabetes control problem. Focusing on personalized health services, supported by health care institutions, and based on regional information platforms, the scheme uses mobile Internet, biosensors, Big data, artificial intelligence and other technical means to build a comprehensive and standardized blood glucose management covering diabetes screening → specialist diagnosis and treatment → grassroots management → family management. It is reported that Suzhou Yiduoyun Information Technology Co., Ltd., a holding company of Jiangsu Hengrui Medicine, is committed to improving medical efficiency and quality, providing intelligent medical Internet services and digital medical products, with digital medicine as its strategic development direction.